Instalab

SIBO Panel

Find out whether misplaced gut microbes are driving the bloating and digestive trouble that never fully resolves.

Should you take a SIBO Panel test?

This test is most useful if any of these apply to you.

Dealing with Chronic Bloating
This panel reveals whether bacterial overgrowth is behind the persistent bloating that dietary changes have not fixed.
Living with IBS Symptoms
Up to one in three people with IBS may have underlying overgrowth that this breath test can identify.
Struggling with Unexplained Constipation
Methane-producing organisms slow your gut and cause constipation that standard tests miss but this panel can detect.
Treated for SIBO Before
Recurrence is common after treatment, and retesting confirms whether the overgrowth has truly cleared.

About SIBO Panel

Bloating after meals, persistent diarrhea, or constipation that shifts without a clear trigger rank among the most common reasons people see a gastroenterologist. In a large portion of these cases, the cause turns out to be microorganisms growing where they should not: in the small intestine rather than the colon (large intestine), a condition called small intestinal bacterial overgrowth (SIBO).

This breath test panel measures three gases after you drink a sugar solution. Each gas points to a different type of overgrowth. Together, they separate classic bacterial overgrowth from a distinct condition driven by methane-producing organisms, a distinction that changes the treatment path entirely.

What This Panel Reveals

The test relies on a straightforward principle. When microbes in the small intestine encounter sugars that should have been absorbed further upstream, they ferment those sugars and release gases. Those gases enter the bloodstream, travel to the lungs, and show up in your breath within minutes.

By measuring gases at timed intervals after drinking a test solution (usually lactulose or glucose), the panel maps your gut's gas output over two to three hours. Three distinct measurements create the clinical picture.

Hydrogen gas signals classic bacterial overgrowth. The North American Consensus on breath testing defines a positive result as a hydrogen rise of 20 parts per million (ppm) or more above your baseline within the first 90 minutes. This pattern is most common in people with diarrhea-predominant symptoms, because the overgrown bacteria interfere with normal digestion and draw excess water into the intestine.

Methane tells a different story. It is not produced by bacteria at all. It comes from a separate group of single-celled organisms called archaea, which are biologically distinct from bacteria. The primary species involved is Methanobrevibacter smithii. Because these organisms can thrive anywhere in the intestinal tract, the condition they cause is now called intestinal methanogen overgrowth (IMO) rather than SIBO. A methane level of 10 ppm or higher at any point during the test is considered positive. A combined analysis of multiple breath testing studies found that methane-positive individuals were more than three times as likely to have constipation compared to methane-negative individuals.

The third measurement, peak hydrogen combined with carbon dioxide (CO₂), functions as a sample quality check. CO₂ levels in exhaled air confirm that you provided a proper deep-lung breath sample rather than shallow mouth air. This correction ensures the hydrogen and methane values accurately reflect intestinal gas production rather than sampling error.

How to Read Your Results Together

The diagnostic power of this panel comes from reading the gases as a pattern, not as individual numbers. The table below shows the four most common result combinations and what each one suggests.

PatternHydrogenMethaneWhat It Suggests
Classic SIBO20 ppm or more rise within 90 minBelow 10 ppmBacterial overgrowth in the small intestine, often linked to diarrhea, bloating, and excess gas
IMOMay be low or flat10 ppm or more at any pointMethanogen overgrowth, strongly associated with constipation and slow transit
Mixed overgrowth20 ppm or more rise10 ppm or moreBoth bacterial and methanogen overgrowth present, may cause alternating diarrhea and constipation
Flat-lineNo significant riseBelow 10 ppmMay indicate hydrogen sulfide-producing organisms (not captured by this panel) or an inadequate test

The flat-line pattern deserves close attention. Some people with clear SIBO symptoms produce neither hydrogen nor methane because their gut organisms generate hydrogen sulfide instead. Standard two-gas breath tests cannot detect hydrogen sulfide. If your results show no meaningful rise in either gas but your symptoms persist, a three-gas breath test that includes hydrogen sulfide measurement or direct sampling of small bowel fluid may be the next step.

When Results Can Be Misleading

Several factors can distort all three measurements at once. Antibiotics taken within two to four weeks before the test suppress microbial gas production and can cause false-negative results. Prokinetic medications (drugs that speed up gut movement) and laxatives speed gut transit, which can make gas from the large intestine appear earlier than expected and mimic a small intestinal source.

Diet in the 24 hours before the test significantly affects baseline gas levels. High-fiber foods, legumes, and other complex sugars that gut bacteria can easily break down can raise starting hydrogen values and make the results harder to interpret. Most protocols require a preparatory diet of simple, low-residue foods (white rice, plain chicken, eggs) for 24 hours before testing. Smoking, exercise during the collection period, and recent colonoscopy preparation can also skew results.

Gut transit speed introduces another variable. If your intestines move food quickly, sugars may reach the large intestine before the 90-minute cutoff, producing a hydrogen spike that looks like SIBO but actually reflects normal fermentation in the colon. Conversely, very slow transit can delay the signal and cause a false-negative reading.

Tracking Over Time

A single breath test tells you whether overgrowth is present right now. Repeated testing after treatment reveals whether the intervention worked and whether overgrowth has come back. Recurrence is common: one study found that roughly 44% of patients who cleared SIBO after antibiotic treatment tested positive again within nine months.

Retesting four to six weeks after completing treatment confirms whether eradication succeeded. If symptoms return months later, a follow-up test can catch recurrence before nutrient deficiencies develop. For people with conditions that predispose them to SIBO (reduced stomach acid, slow gut motility, or structural abnormalities), testing every six to twelve months makes sense as part of ongoing monitoring.

What to Do with Your Results

Treatment differs based on which gas is elevated. Hydrogen-positive results and methane-positive results require different antibiotic strategies, which is one of the main reasons the panel measures both gases separately. Work with a gastroenterologist to match the treatment to your specific gas pattern.

Beyond treatment, a positive result should prompt investigation into the underlying cause. SIBO rarely appears in isolation. Common drivers include reduced stomach acid (from long-term acid-blocking medication use or autoimmune gastritis), slow gut motility (from hypothyroidism, diabetes, or certain neurological conditions), and structural issues like surgical adhesions or diverticula (small pouches that form in the intestinal wall).

If results are negative but symptoms continue, consider adding a stool-based panel to evaluate gut inflammation and microbial balance, testing for celiac disease, or requesting hydrogen sulfide breath testing where available. A gastroenterologist can help determine whether direct sampling of small bowel fluid is warranted.

Frequently Asked Questions

References

6 studies
  1. Rezaie a, Buresi M, Lembo a, Lin HC, Andreuzzi P, Pimentel MAmerican Journal of Gastroenterology2017
  2. Pimentel M, Saad RJ, Long MD, Rao SSCAmerican Journal of Gastroenterology2020
  3. Kunkel D, Basseri RJ, Makhani MD, Chong K, Chang C, Pimentel MDigestive Diseases and Sciences2011
  4. Lauritano EC, Gabrielli M, Scarpellini E, Lupascu a, Novi M, Sottili SAmerican Journal of Gastroenterology2008
  5. Shah a, Talley NJ, Jones M, Kendall BJ, Koloski N, Walker MMAmerican Journal of Gastroenterology2020